Krka Sued over Patent Infringement in Denmark

Novo Mesto, 11 April - Two subsidiaries of drugs giant AstraZeneca have filed a motion at a Copenhagen court seeking EUR 9.6m from the Swedish subsidiary of Slovenian drug maker Krka, Krka Sverige, over alleged infringement of a patent on the active substance esomperazole.